Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Biological & Pharmaceutical Bulletin|November 3, 2017
Riboflavin Transporters RFVT/SLC52A Mediate Translocation of Riboflavin, Rather than FMN or FAD, across Plasma MembraneCongyun Jin, Yoshiaki Yao, Atsushi Yonezawa, et al.
Journal of Applied Clinical Medical Physics|March 9, 2013
Source strength assay of iodine-125 seeds sealed within sterile packagingYuki Otani, Takahiro Yamada, Shingo Kato, et al.
Springerplus|November 7, 2015
Correlation between patients' anatomical characteristics and interfractional internal prostate motion during intensity modulated radiation therapy for prostate cancerShintaroh Maruoka, Yasuo Yoshioka, Fumiaki Isohashi, et al.
Advances in Therapy|March 21, 2025
Pharmacokinetic Comparability and Safety Between Original and Citrate-Free Mirikizumab Formulations for Subcutaneous Injections: Results from Three Clinical TrialsYuki Otani, Brian G Feagan, Geert R D'Haens, et al.
Journal of Biomedical Materials Research. Part A|June 30, 2022
Modified foreign body reaction to silicone imbedded in subcutaneous tissues by different mouse systemic immune conditionsTomohiro Yamakawa, Osamu Ichii, Teppei Nakamura, et al.
Journal of the American Society of Nephrology : JASN|October 23, 2021
Close Association between Altered Urine-Urothelium Barrier and Tertiary Lymphoid Structure Formation in the Renal Pelvis during NephritisOsamu Ichii, Marina Hosotani, Md Abdul Masum, et al.
The Journal of Reproduction and Development|September 4, 2020
Unique morphological characteristics in the ovary of cotton rat (Sigmodon hispidus)Md Rashedul Islam, Osamu Ichii, Teppei Nakamura, et al.
Research in Veterinary Science|July 19, 2022
Ureteral morphology and pathology during urolithiasis in catsOsamu Ichii, Kazuhisa Oyamada, Hazuki Mizukawa, et al.
ACS Chemical Biology|August 14, 2020
Novel Tetrafunctional Probes Identify Target Receptors and Binding Sites of Small-Molecule Drugs from Living SystemsRin Miyajima, Koji Sakai, Yuki Otani, et al.
The Lancet. Gastroenterology & Hepatology|November 21, 2025
Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trialJess L Kaplan, Athos Bousvaros, Dan Turner, et al.
Pageof 9